Potentiation of the Effect of Orally Administered Anticoagulants by Phenyramidol Hydrochloride
- 19 August 1965
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 273 (8) , 423-426
- https://doi.org/10.1056/nejm196508192730805
Abstract
IT is well known that administration of one drug may inhibit or potentiate the effect of another.1 Such an interaction is of particular clinical importance when anticoagulants are given, because its recognition may prevent serious hemorrhagic complications and may result in a smoother control of the prothrombin time. This report deals with the effect of phenyramidol hydrochloride (Analexin) on the response to orally administered anticoagulants. To my knowledge this is the first report on this action of phenyramidol.Phenyramidol is a 2-(beta-hydroxyphenethylamino)-pyridine hydrochloride marketed for use in acute and chronic conditions in which both muscle spasm and pain are involved. . . .Keywords
This publication has 4 references indexed in Scilit:
- Implications of enzyme induction for drug therapyThe American Journal of Medicine, 1964
- Potentiation of Anticoagulants Caused by Pyrazole CompoundsJAMA, 1964
- THE INFLUENCE OF BARBITURATES ON COUMARIN PLASMA LEVELS AND PROTHROMBIN RESPONSE*Journal of Clinical Investigation, 1961
- ANALGESIC EFFECTIVENESS OF PHENYRAMIDOL HYDROCHLORIDE, A NEW AMINOPYRIDINE DERIVATIVEThe Lancet Healthy Longevity, 1959